Hao Wu

Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial

Calvin Cohen, Jaime Andrade‐Villanueva, Bonaventura Clotet et al. · The Lancet · 2011 · 369 citations

Treatment And Prevention, Medicine, Human Retrovirus +9

PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors

Ji‐Yuan Zhang, Zheng Zhang, Xicheng Wang et al. · Blood · 2007 · 294 citations · Full text

Efficacy and Safety of Rilpivirine (TMC278) Versus Efavirenz at 48 Weeks in Treatment-Naive HIV-1–Infected Patients

Calvin Cohen, Jean‐Michel Molina, Pedro Cahn et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2012 · 158 citations

Pharmacotherapy, Antiviral Drug, Drug Resistance +17

Mapping of Antigenic Sites on the Nucleocapsid Protein of the Severe Acute Respiratory Syndrome Coronavirus

Yuxian He, Yusen Zhou, Hao Wu et al. · Journal of Clinical Microbiology · 2004 · 92 citations · Full text

Viral Replication, Viral Diagnostics, Humoral Response +16

Plasma IP-10 Is Associated with Rapid Disease Progression in Early HIV-1 Infection

Yanmei Jiao, Tong Zhang, Rui Wang et al. · Viral Immunology · 2012 · 83 citations

Early Hiv-1 Infection, Disease Progression, Immunodeficiencies +21